Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial.
Journal: Journal of cachexia, sarcopenia and muscle
Published: May 28, 2024
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
Journal: The New England journal of medicine
Published: May 11, 2022
Performance Evaluation of the Quantitative Point-of-Care LumiraDx D-Dimer Test.
Journal: Cardiology and therapy
Published: July 19, 2021
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study.
Journal: Human vaccines & immunotherapeutics
Published: April 03, 2020
Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: December 22, 2017
Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults.
Journal: BMC infectious diseases
Published: November 22, 2017
Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2-10 Years of Age.
Journal: The Pediatric infectious disease journal
Published: September 24, 2015
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.
Journal: Vaccine
Published: June 23, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026